In addition to 17-AAG, other factors such as replication licensing factor (Cdc6) can negatively regulate the transcription activity of E-cadherin in human cancer 36, and no evidence indicates whether Cdc6 is implicated in the regulation of 17-AAG on E-cadherin. The gene discussed is CDC6; the disease is cancer.